AAAAAA
Results:
1-25
|
Results: 25
Authors:
SEIPELT G
HOFMANN WK
MARTIN H
WASSMANN B
BOEHME A
OTTMANN OG
HOELZER D
Citation: G. Seipelt et al., COMPARISON OF TOXICITY AND OUTCOME IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH HIGH-DOSE CYTOSINE-ARABINOSIDE CONSOLIDATION AFTER INDUCTION WITH A REGIMEN CONTAINING IDARUBICIN OR DAUNORUBICIN, Annals of hematology, 76(3-4), 1998, pp. 145-151
Authors:
MARTIN H
SEIPELT G
OTTMANN OG
RODE C
SONNHOF S
ATTA J
HOELZER D
Citation: H. Martin et al., VARIATION OF PERIPHERAL CD34+ PEAKS IN PATIENTS WITH AML AFTER 3 CYCLES OF CHEMOTHERAPY, British Journal of Haematology, 102(1), 1998, pp. 80-80
Authors:
RAGHAVACHAR A
KOLBE K
HOFFKEN K
SEIPELT G
BURK M
GEISSLER RG
PASOLD R
ZWINGERS T
SCHREZENMEIER H
Citation: A. Raghavachar et al., STANDARD IMMUNOSUPPRESSION IS SUPERIOR TO CYCLOSPORINE FILGRASTIM IN SEVERE APLASTIC-ANEMIA/, British Journal of Haematology, 102(1), 1998, pp. 154-154
Authors:
HOFMANN WK
GANSER A
OTTMANN OG
SEIPELT G
ZANDER C
FISCHER JT
HOFFKEN K
HOFFMANN K
HOELZER D
Citation: Wk. Hofmann et al., LONG-TERM COMPLETE REMISSIONS IN PATIENTS WITH LOW-RISK MYELODYSPLASTIC SYNDROMES DURING COMBINATION TREATMENT USING ALL-TRANS-RETINOIC ACID, British Journal of Haematology, 102(1), 1998, pp. 343-343
Authors:
OTTMANN OG
SEIPELT G
HOELZER D
Citation: Og. Ottmann et al., CLINICAL USE OF HEMATOPOIETIC COLONY-STIM ULATING FACTORS - WHEN AND WHERE, Der Internist, 38(12), 1997, pp. 1160-1167
Authors:
HOFMANN WK
GANSER A
OTTMANN OG
SEIPELT G
ZANDER C
GEISSLER RG
FISCHER JT
HOFFKEN K
HOFFMANN K
HOELZER D
Citation: Wk. Hofmann et al., ALL-TRANS-RETINOIC ACID (ATRA), INTERFERON-ALPHA (IFN-ALPHA) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS COMBINATION THERAPY IN PATIENTS WITH LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS), Blood, 90(10), 1997, pp. 366-366
Authors:
MARTIN H
ATTA J
FAUTH F
KEYSER M
OTT MG
OTTMANN OG
SEIPELT G
WASSMANN B
HOELZER D
Citation: H. Martin et al., SEQUENTIAL AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 90(10), 1997, pp. 1712-1712
Authors:
RAGHAVACHAR A
KOLBE K
HOFFKEN K
SEIPELT G
BURK M
GANSER A
PASOLD R
ZWINGERS T
SCHREZENMEIER H
Citation: A. Raghavachar et al., A RANDOMIZED TRIAL OF STANDARD IMMUNOSUPPRESSION VERSUS CYCLOSPORINE AND FILGRASTIM IN SEVERE APLASTIC-ANEMIA, Blood, 90(10), 1997, pp. 1951-1951
Authors:
KIRCHNER J
SEIPELT G
HEYD R
DIETRICH CF
JACOBI V
Citation: J. Kirchner et al., EXTENSIVE PNEUMOPERITONEUM DURING TREATME NT OF A LYMPHOMA WITH METHOTREXATE AND CYTOSINE-ARABINOSIDE, Deutsche Medizinische Wochenschrift, 121(42), 1996, pp. 1288-1291
Authors:
GANSER A
MAURER A
CONTZEN C
SEIPELT G
OTTMANN OG
SCHADECKGRESSEL C
KOLBE K
HAAS R
ZANDER C
REUTZEL R
HOELZER D
Citation: A. Ganser et al., IMPROVED MULTILINEAGE RESPONSE OF HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TO A COMBINATION THERAPY WITH ALL-TRANS-RETINOIC- ACID, GRANULOCYTE-COLONY-STIMULATING FACTOR, ERYTHROPOIETIN AND ALPHA-TOCOPHEROL, Annals of hematology, 72(4), 1996, pp. 237-244
Authors:
HOFMANN WK
OTTMANN OG
WAGNER S
SEIPELT G
KALINA U
HOELZER D
Citation: Wk. Hofmann et al., EFFECT OF C-MPL LIGAND ON IN-VITRO MEGAKARYOPOIESIS IN MYELODYSPLASTIC SYNDROMES, Experimental hematology, 24(9), 1996, pp. 574-574
Authors:
HEIL G
HERRMANN F
HOELZER D
SEIPELT G
EDER M
HUBER C
KOLBE K
MERTELSMANN R
LINDEMANN A
FRISCH J
NICOLAY C
GAUS W
HEIMPEL H
Citation: G. Heil et al., GM-CSF PRIMING IN THE THERAPY OF DE-NOVO AML PATIENTS - AN UPDATE OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED, Blood, 88(10), 1996, pp. 828-828
Authors:
HEIL G
CHADID L
HOELZER D
SEIPELT G
MITROU P
HUBER C
KOLBE K
MERTELSMANN R
LINDEMANN A
FRISCH J
NICOLAY U
GAUS W
HEIMPEL H
Citation: G. Heil et al., GM-CSF IN A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN THERAPY OF ADULT PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML), Leukemia, 9(1), 1995, pp. 3-9
Authors:
SEIPELT G
HOELZER D
Citation: G. Seipelt et D. Hoelzer, NEW DEVELOPMENTS IN THE TREATMENT OF CHRO NIC AND ACUTE LEUKEMIAS, Schweizerische medizinische Wochenschrift, 125(27-28), 1995, pp. 1354-1363
Authors:
MAURER AB
GANSER A
SEIPELT G
OTTMANN OG
MENTZEL U
GEISSLER GR
HOELZER D
Citation: Ab. Maurer et al., CHANGES IN ERYTHROID PROGENITOR-CELL AND ACCESSORY CELL COMPARTMENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DURING TREATMENT WITH ALL-TRANS-RETINOIC ACID AND HEMATOPOIETIC GROWTH-FACTORS, British Journal of Haematology, 89(3), 1995, pp. 449-456
Authors:
GANSER A
HEIL G
HOFMANN WK
OTTMANN OG
SEIPELT G
FISCHER JT
LANGER W
BROCKHAUS W
ITTEL TH
BRACK N
KNUTH A
HOFFKEN K
KLAUSMANN M
FUHR HG
BERGMANN L
HOELZER D
Citation: A. Ganser et al., AGGRESSIVE CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, AMSACRIN, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR ADVANCED MYELODYSPLASTIC SYNDROMES AND HIGH-RISK ANLL, Blood, 86(10), 1995, pp. 1722-1722
Authors:
SEIPELT G
GANSER A
DURANCEYK H
MAURER A
OTTMANN OG
HOELZER D
Citation: G. Seipelt et al., INDUCTION OF SOLUBLE IL-2 RECEPTOR IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES UNDERGOING HIGH-DOSE INTERLEUKIN-3 TREATMENT, Annals of hematology, 68(4), 1994, pp. 167-170
Authors:
GANSER A
SEIPELT G
VERBEEK W
OTTMANN OG
MAURER A
KOLBE K
HESS U
ELSNER S
REUTZEL R
WORMANN B
HIDDEMANN W
HOELZER D
Citation: A. Ganser et al., EFFECT OF COMBINATION THERAPY WITH ALL-TRANS-RETINOIC ACID AND RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia, 8(3), 1994, pp. 369-375
Authors:
GANSER A
OTTMANN OG
SEIPELT G
LINDEMANN A
HESS U
GEISSLER G
MAURER A
FRISCH J
SCHULZ G
MERTELSMANN R
HOELZER D
Citation: A. Ganser et al., EFFECT OF LONG-TERM TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-3 INPATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia, 7(5), 1993, pp. 696-701
Authors:
MAURER AB
GANSER A
BUHL R
SEIPELT G
OTTMANN OG
MENTZEL U
GEISSLER RG
HOELZER D
Citation: Ab. Maurer et al., RESTORATION OF IMPAIRED CYTOKINE SECRETION FROM MONOCYTES OF PATIENTSWITH MYELODYSPLASTIC SYNDROMES AFTER IN-VIVO TREATMENT WITH GM-CSF ORIL-3, Leukemia, 7(11), 1993, pp. 1728-1733
Authors:
MAURER AB
GANSER A
OTTMANN OG
MENTZEL U
SEIPELT G
GEISSLER G
HOELZER D
Citation: Ab. Maurer et al., EFFECT OF ALL-TRANS-RETINOIC ACID AND G-CSF ON PROLIFERATION AND DIFFERENTIATION OF MYELOID PROGENITORS AND PRIMING OF ACCESSORY CELLS - IN-VIVO AND IN-VITRO RESULTS, Experimental hematology, 21(8), 1993, pp. 1034-1034
Authors:
GANSER A
MAURER A
BUHL R
OTTMANN OG
SEIPELT G
GEISSLER G
HOELZER D
Citation: A. Ganser et al., RESTORATION OF NORMAL MONOCYTE MACROPHAGE FUNCTION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DURING HEMATOPOIETIC GROWTH-FACTOR THERAPY (IL-3, GM-CSF)/, Experimental hematology, 21(8), 1993, pp. 1152-1152
Authors:
SEIPELT G
GANSER A
DURANCEYK H
MAURER A
OTTMANN OG
HOELZER D
Citation: G. Seipelt et al., INDUCTION OF TNF-ALPHA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES UNDERGOING TREATMENT WITH INTERLEUKIN-3, British Journal of Haematology, 84(4), 1993, pp. 749-751
Authors:
GANSER A
HEIL G
SEIPELT G
FISCHER JT
LANGER G
BROCKHAUS W
ITTEL TH
FUHR HG
BERGMANN L
HOELZER D
Citation: A. Ganser et al., AGGRESSIVE INDUCTION CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR HIGH-RISK ANLL, Blood, 82(10), 1993, pp. 10000128-10000128
Authors:
GANSER A
OTTMANN OG
SCHADECKGRESSEL C
KOLBE K
HAAS R
SEIPELT G
MAURER A
ZANDER C
REUTZEL R
HOELZER D
Citation: A. Ganser et al., COMBINATION THERAPY WITH ALL-TRANS-RETINOIC ACID (ATRA), GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF), ERYTHROPOIETIN (EPO) AND VITAMIN-E IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 82(10), 1993, pp. 10000377-10000377
Risultati:
1-25
|